Survey the effect of saffron on asthma
Phase 1
- Conditions
- moderate persistent allergic asthma.
- Registration Number
- IRCT2017012132081N2
- Lead Sponsor
- Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
age between 18 to 65 years old, moderate persistent allergic asthma (FEV1 between 40 to 60 percent) according to the physician and normal BMI (up to 27). Inclusion criteria dos not belong to the particular gender and include male and females.
Exclusion criteria include smoking, diabetes, pregnancy and lactation, autoimmune disease, malignancies, gastrointestinal, liver and kidney disease, pneumonia and other pulmonary disease and Not wanting to continue cooperation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antibody titers to heat shock protein 70. Timepoint: Before and two months after intervention. Method of measurement: according to the Laboratory Measurement-ng/ml.;FEV1, FVC, FEV1/FVC. Timepoint: Before and two months after intervention. Method of measurement: According to the results of the spirometer-scale:percent.
- Secondary Outcome Measures
Name Time Method HsCRP. Timepoint: Before and two months after intervention. Method of measurement: according to the laboratory measurement-mg/dl.;Lipid profile. Timepoint: Before and two months after intervention. Method of measurement: according to the laboratory measurement-mg/dl.;Blood presure. Timepoint: Before and two months after intervention. Method of measurement: according to the results of Sphygmomanometer-mmhg.;Clinical variables and the patient's general status. Timepoint: Before and two months after intervention. Method of measurement: according to the Questionnaires completed by physician superspecialty.